3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
5
Polycystic Ovary Syndrome
2
Leukemia, Myeloid, Acute
2
Head and Neck Neoplasms
2
Triple Negative Breast Neoplasms
1
Tracheal Diseases
1
TP53 Y220C Mutation
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Salivary Gland Neoplasms
1
Peripheral Nervous System Diseases
1
Pancreatic Neoplasms
1
Obesity
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Motor Activity
1
Mesothelioma
1
Meningioma
1
Medulloblastoma
1
Lymphoma
1
Lung Neoplasms
1
Localized Prostate Cancer
1
Leukemia
1
Leiomyosarcoma
1
Laryngeal Diseases
1
Inflammation
1
Interventions
Cyclophosphamide
6
Temozolomide
5
Etoposide
5
Vincristine
3
Radiotherapy
3
Cisplatin
3
lutetium Lu 177 dotatate
2
etoposide phosphate
2
Radiation
2
Filgrastim
2
Celecoxib
2
Carboplatin
2
sodium thiosulfate
1
ribociclib
1
pegfilgrastim
1
palbociclib
1
olaparib
1
ibrutinib
1
fludarabine
1
fenofibric acid
1
abemaciclib
1
Topotecan
1
Thiotepa
1
Thalidomide
1
Tamoxifen
1
Tablets
1
Standard of Care
1
Specimen Handling
1
Platinum
1
ONC206
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Medulloblastoma
×
Tablets
×
Clear all
NCT05230758
2026-05-01
Met Med Can
The Hospital for Sick Children
Phase 3
Recruiting
140 enrolled